CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Previous Lecture Series Sessions - 2014

Hollow Hunt for Harms

On December 4, 2014, Dr. Jacob Stegenga talked about how we can address medical intervention harms, which are often underestimated throughout the clinical trial process.

Watch the webinar


Dr. Jacob Stegenga

Assistant Professor, Department of Philosophy, University of Utah

It's Time to Break Our Addiction to Technology Adoption: Reframing HTA as the Cornerstone of "Resource Stewardship"

On November 17, 2014, Dr. Stirling Bryan gave a thought-provoking discussion about important considerations related to value and the reimbursement of high-cost health technologies.

Watch the webinar


Dr. Stirling Bryan
Director, Centre for Clinical Epidemiology and Evaluation, University of British Columbia

Roadmap to a Rational Pharmacare Policy in Canada

On October 28, 2014, Dr. Marc-André Gagnon talked about the challenges of the hybrid prescription drug system and how implementing practical reforms can result in improving access.

Watch the webinar


Dr. Marc-André Gagnon
School of Public Policy and Administration, Carleton University

Using Citizens' Juries in Health Policy Decision-Making: A Systematic Review and Personal Reflection

On October 8, 2014, Professor Annette Braunack-Mayer used various public health examples to illustrate how citizens' juries are used to engage the public in health policy decision-making.

Watch the webinar


Professor Annette Braunack-Mayer
Head of the School of Population Health, and Professor in Ethics in the Discipline of Public Health, University of Adelaide

It's Time to Stop Paying for Lemons in Health Care: Linking Payment to Results for Medical Technologies

On September 25, 2014, Professor Christopher McCabe joined us to talk about how linking reimbursement to health technology performance results in improved health outcomes and resource savings.

Watch the webinar


Professor Christopher McCabe
Health Economist and Principal Investigator, PACEOMICS
Capital Health Endowed Research Chair, Emergency Medicine Research, University of Alberta

Translating Personalized Genomic Medicine: Evidence, Values, and Health Policy

On July 3, 2014, Dr. Yvonne Bombard, a rising star in Canadian health research and inaugural recipient of the CADTH Maurice McGregor Award, gave us her insights on the increasing enthusiasm for genomics and its promise in advancing personalized medicine. She talked about how new genomic technologies offer exciting opportunities for patient treatment, but also present challenges with translating genomic technologies into routine clinical practice. She also stressed the importance of engaging both the patient and the public as the science, delivery, and organization of personalized medicine develops.

Watch the webinar


Dr. Yvonne Bombard
Scientist, Li Ka Shing Knowledge Institute of St. Michael's Hospital
Assistant Professor, Institute of Health Policy, Management & Evaluation, University of Toronto

Evolution of HTA in Scotland: Lessons for Canada?

On June 23, 2014, Dr. Karen Facey, one of the top 100 practising scientists in the UK, gave us an insider's look at the evolution of HTA in Scotland — and what these trends could mean for HTA in Canada. She described how Scotland's HTA processes have changed as a result of experience, stakeholder engagement, and political pressure, culminating in recent radical changes to the way the Scottish Medicine Consortium conducts its business.

Watch the webinar


Dr. Karen Facey
Founding Chief Executive of the Health Technology Board for Scotland
Honorary Senior Research Fellow, University of Glasgow

A Personal Perspective on Health Technology Assessment in Canada

On January 14, 2014, Dr. Devidas Menon, the first Executive Director for CCOHTA (the precursor to CADTH), kicked off our lecture series by giving us his insights about the early days of HTA in Canada, as well as his thoughts about how HTA has evolved over the years.


Dr. Devidas Menon
Professor, University of Alberta, School of Public Health